SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-012271
Filing Date
2024-08-14
Accepted
2024-08-14 17:05:26
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cycc-20240630x10q.htm   iXBRL 10-Q 1381568
2 EX-31.1 cycc-20240630xex31d1.htm EX-31.1 14605
3 EX-31.2 cycc-20240630xex31d2.htm EX-31.2 15137
4 EX-32.1 cycc-20240630xex32d1.htm EX-32.1 5068
5 EX-32.2 cycc-20240630xex32d2.htm EX-32.2 5137
6 GRAPHIC cycc-20240630x10q001.jpg GRAPHIC 19511
7 GRAPHIC cycc-20240630x10q002.jpg GRAPHIC 33401
  Complete submission text file 0001558370-24-012271.txt   6087773

Data Files

Seq Description Document Type Size
8 EX-101.SCH cycc-20240630.xsd EX-101.SCH 47121
9 EX-101.CAL cycc-20240630_cal.xml EX-101.CAL 36239
10 EX-101.DEF cycc-20240630_def.xml EX-101.DEF 226846
11 EX-101.LAB cycc-20240630_lab.xml EX-101.LAB 363756
12 EX-101.PRE cycc-20240630_pre.xml EX-101.PRE 311915
67 EXTRACTED XBRL INSTANCE DOCUMENT cycc-20240630x10q_htm.xml XML 838052
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 241209364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)